Global Pharma Parenteral Packaging Market Size is valued at USD 13.6 Billion in 2024 and is predicted to reach USD 21.5 Billion by the year 2034 at a 4.8% CAGR during the forecast period for 2025-2034.
Pharma parenteral packaging describes the unique techniques developed for storing and administering sterile pharmaceuticals through infusion, intramuscular, or epidermal injections rather than the digestive tract. These packaging techniques guarantee that the product will remain intact, sterile, and safe throughout its entire lifecycle, from storage to transit to administration. The growing prevalence of chronic diseases and injectable drug usage, growing focus on improving patient safety, rising use of biologics, and growing use of prefilled syringes and injection devices are expected to lead to an increase in the need for pharma parenteral packaging solutions and support the growth of the market.
However, the market growth is estimated to be hampered by the stringent government regulations and standards and, the cost of raw materials used in pharma parenteral packaging.
The pharma parenteral packaging market is segmented based on drug type, product type, packaging type and material. Based on drug type, the market is segmented into small molecules, biologics, vaccines, and biosimilars. By product type, the market is segmented into bottles, ampoules, vials, prefilled syringes, and cartridges. By material, the market is segmented into glass, polymer, PVC, and others. By packaging type, the market is segmented into small-volume parenteral and large-volume parenteral.
The prefilled syringes pharma parenteral packaging market is expected to hold a significant global market share in 2024. Ease of use of prefilled syringes, preference for small molecules in prefilled syringes over other dosage forms, lower dosage errors and growing demand for prefilled insulin syringes due to increasing cases of diabetes are driving growth in pharma parenteral packaging globally.
The glass industry makes up the bulk of pharma parenteral packaging because Glass is used for various purposes and can be found in many different goods. It is a commonly utilized raw material in parenteral packaging due to its impermeable and non-porous nature, which allows it to retain product composition. Glass also protects items from ultraviolet radiation, which means they stay fresh for longer, especially in countries like the US, Germany, the U.K., China, and India.
The North American pharma parenteral packaging market is expected to register the highest market share in revenue in the near future. This can be attributed to the presence of prominent parenteral packaging businesses, the increasing need for injectable medication packaging, and the pharmaceutical industry's overall growth. In addition, Asia Pacific region is projected to grow at the highest growth rate during study period because of the increasing incidence of chronic and infectious diseases, the growing need for pharmaceutical vial packaging, and the rise in vaccination programs.
|
Report Attribute |
Specifications |
|
Market Size Value In 2024 |
USD 13.6 Billion |
|
Revenue Forecast In 2034 |
USD 21.5 Billion |
|
Growth Rate CAGR |
CAGR of 4.8% from 2025 to 2034 |
|
Quantitative Units |
Representation of revenue in US$ Mn, Volume (Tons) and CAGR from 2025 to 2034 |
|
Historic Year |
2021 to 2024 |
|
Forecast Year |
2025-2034 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Drug Type, By Product Type, By Material, By Packaging Type |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; South East Asia; South Korea |
|
Competitive Landscape |
Adelphi Healthcare Packaging, Akorn, Inc., Alcami Corporation, Inc., Ardena Holding NV, Baxter International Inc., Becton, Dickinson and Company, Berkshire Sterile Manufacturing, Berry Global Inc., Catalent Inc., Gerresheimer AG., Nipro Corporation, PCI Pharma Services, Schott AG, SGD Pharma, SiO2 Materials Science., Stevanato Group S.p.A, Terumo Corporation, UDG Healthcare Plc., West Pharmaceutical Services, Inc., Ypsomed Holding AG |
|
Customization Scope |
Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your specific requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Pharma Parenteral Packaging Market Snapshot
Chapter 4. Global Pharma Parenteral Packaging Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Product Type Estimates & Trend Analysis
5.1. by Product Type & Market Share, 2024 & 2034
5.2. Market Size (Value (US$ Mn) & Volume (Tons)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Product Type:
5.2.1. Bottles
5.2.2. Ampoules
5.2.3. Vials
5.2.4. Prefilled syringes
5.2.5. Cartridges
5.2.6. Others
Chapter 6. Market Segmentation 2: by Drug Type Estimates & Trend Analysis
6.1. by Drug Type & Market Share, 2024 & 2034
6.2. Market Size (Value (US$ Mn) & Volume (Tons)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Drug Type:
6.2.1. Small Molecules
6.2.2. Biologics
6.2.3. Vaccines
6.2.4. Biosimilars
6.2.5. Others
Chapter 7. Market Segmentation 3: by Material Estimates & Trend Analysis
7.1. by Material & Market Share, 2024 & 2034
7.2. Market Size (Value (US$ Mn) & Volume (Tons)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Material:
7.2.1. Glass
7.2.2. Polymer
7.2.3. PVC
7.2.4. Others
Chapter 8. Market Segmentation 4: by Packaging Type Estimates & Trend Analysis
8.1. by Packaging Type & Market Share, 2024 & 2034
8.2. Market Size (Value (US$ Mn) & Volume (Tons)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Packaging Type:
8.2.1. Small Volume Parenteral
8.2.2. Large Volume Parenteral
Chapter 9. Pharma Parenteral Packaging Market Segmentation 5: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. North America Pharma Parenteral Packaging Market Revenue (US$ Million) & Volume (Tons) Estimates and Forecasts by Product Type, 2021-2034
9.1.2. North America Pharma Parenteral Packaging Market Revenue (US$ Million) & Volume (Tons) Estimates and Forecasts by Drug Type, 2021-2034
9.1.3. North America Pharma Parenteral Packaging Market Revenue (US$ Million) & Volume (Tons) Estimates and Forecasts by Material, 2021-2034
9.1.4. North America Pharma Parenteral Packaging Market Revenue (US$ Million) & Volume (Tons) Estimates and Forecasts by Packaging Type, 2021-2034
9.1.5. North America Pharma Parenteral Packaging Market Revenue (US$ Million) & Volume (Tons) Estimates and Forecasts by country, 2021-2034
9.2. Europe
9.2.1. Europe Pharma Parenteral Packaging Market Revenue (US$ Million) & Volume (Tons) Estimates and Forecasts by Product Type, 2021-2034
9.2.2. Europe Pharma Parenteral Packaging Market Revenue (US$ Million) & Volume (Tons) Estimates and Forecasts by Drug Type, 2021-2034
9.2.3. Europe Pharma Parenteral Packaging Market Revenue (US$ Million) & Volume (Tons) Estimates and Forecasts by Material, 2021-2034
9.2.4. Europe Pharma Parenteral Packaging Market Revenue (US$ Million) & Volume (Tons) Estimates and Forecasts by Packaging Type, 2021-2034
9.2.5. Europe Pharma Parenteral Packaging Market Revenue (US$ Million) & Volume (Tons) Estimates and Forecasts by country, 2021-2034
9.3. Asia Pacific
9.3.1. Asia Pacific Pharma Parenteral Packaging Market Revenue (US$ Million) & Volume (Tons) Estimates and Forecasts by Product Type, 2021-2034
9.3.2. Asia Pacific Pharma Parenteral Packaging Market Revenue (US$ Million) & Volume (Tons) Estimates and Forecasts by Drug Type, 2021-2034
9.3.3. Asia-Pacific Pharma Parenteral Packaging Market Revenue (US$ Million) & Volume (Tons) Estimates and Forecasts by Material, 2021-2034
9.3.4. Asia Pacific Pharma Parenteral Packaging Market Revenue (US$ Million) & Volume (Tons) Estimates and Forecasts by Packaging Type, 2021-2034
9.3.5. Asia Pacific Pharma Parenteral Packaging Market Revenue (US$ Million) & Volume (Tons) Estimates and Forecasts by country, 2021-2034
9.4. Latin America
9.4.1. Latin America Pharma Parenteral Packaging Market Revenue (US$ Million) & Volume (Tons) Estimates and Forecasts by Product Type, 2021-2034
9.4.2. Latin America Pharma Parenteral Packaging Market Revenue (US$ Million) & Volume (Tons) Estimates and Forecasts by Drug Type, 2021-2034
9.4.3. Latin America Pharma Parenteral Packaging Market Revenue (US$ Million) & Volume (Tons) Estimates and Forecasts by Material, 2021-2034
9.4.4. Latin America Pharma Parenteral Packaging Market Revenue (US$ Million) & Volume (Tons) Estimates and Forecasts by Packaging Type, 2021-2034
9.4.5. Latin America Pharma Parenteral Packaging Market Revenue (US$ Million) & Volume (Tons) Estimates and Forecasts by country, 2021-2034
9.5. Middle East & Africa
9.5.1. Middle East & Africa Pharma Parenteral Packaging Market Revenue (US$ Million) & Volume (Tons) Estimates and Forecasts by Product Type, 2021-2034
9.5.2. Middle East & Africa Pharma Parenteral Packaging Market Revenue (US$ Million) & Volume (Tons) Estimates and Forecasts by Drug Type, 2021-2034
9.5.3. Middle East & Africa Pharma Parenteral Packaging Market Revenue (US$ Million) & Volume (Tons) Estimates and Forecasts by Material, 2021-2034
9.5.4. Middle East & Africa Pharma Parenteral Packaging Market Revenue (US$ Million) & Volume (Tons) Estimates and Forecasts by Packaging Type, 2021-2034
9.5.5. Middle East & Africa Pharma Parenteral Packaging Market Revenue (US$ Million) & Volume (Tons) Estimates and Forecasts by country, 2021-2034
Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles
10.2.1 Adelphi Healthcare Packaging
10.2.2 Akorn, Inc.
10.2.3 Alcami Corporation, Inc.
10.2.4 Ardena Holding NV
10.2.5 Baxter International Inc.
10.2.6 Becton, Dickinson and Company
10.2.7 Berkshire Sterile Manufacturing
10.2.8 Berry Global Inc.
10.2.9 Catalent Inc.
10.2.10 Gerresheimer AG.
10.2.11 Nipro Corporation
10.2.12 PCI Pharma Services
10.2.13 Schott AG
10.2.14 SGD Pharma
10.2.15 SiO2 Materials Science.
10.2.16 Stevanato Group S.p.A
10.2.17 Terumo Corporation
10.2.18 UDG Healthcare Plc.
10.2.19 West Pharmaceutical Services, Inc.
10.2.20 Ypsomed Holding AG
By Drug Type-
By Product Type-
By Material-
By Packaging Type
By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
To know more about the research methodology used for this study, kindly contact us/click here.
